Cargando…
The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis
Objective. Examine the impact of comorbid depression on adherence to disease-modifying therapy (DMT) for multiple sclerosis (MS). Methods. A retrospective database was used to identify patients with MS treated with a DMT. Patients with MS and comorbid depression were matched to patients with MS only...
Autores principales: | Tarrants, M., Oleen-Burkey, M., Castelli-Haley, J., Lage, M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196992/ https://www.ncbi.nlm.nih.gov/pubmed/22096632 http://dx.doi.org/10.1155/2011/271321 |
Ejemplares similares
-
Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data
por: Bell, Christopher, et al.
Publicado: (2007) -
Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey
por: Hadjimichael, Olympia, et al.
Publicado: (2008) -
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010
por: Oleen-Burkey, MerriKay, et al.
Publicado: (2014) -
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes
por: Coyle, Patricia K, et al.
Publicado: (2014) -
Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)